Weekly Newsletter

Wednesday, February 5, 2025

Features of the week

CRO

Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing

By Medhealth Outlook
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has announced a long-term strategic partnership with Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK)...
CRO

Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape

By Medhealth Outlook
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has published an in-depth whitepaper titled "Vaccines – Global Clinical Trial Landscape (2024)."...
CRO

Avance Clinical signs MOUs with key Korean trial sites at 2024 KoNECT

By Medhealth Outlook
SEOUL, KOREA | Adelaide, Australia Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical...
Healthcare Diagnostics

Powering a Push to Extract Unheard Levels of Data from Medical Scans

By Medhealth Outlook
Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, has successfully raised a sum of $50 million in Series A financing. Led by Asabys (through its fund Sabadell Asabys II) and Buenavista Equity Partners (through...

Featured Vendors

Featured Insights

Pharma & Life Sciences

Revolutionizing Pharma Production with AI-Powered Solutions

Pavithran Ayyala, Head - Digital IT Services Business & CIO, Utthunga
The global pharmaceutical industry, valued at a staggering $1.6 trillion, remains a cornerstone of global healthcare, yet it faces formidable production challenges. One of the most pressing issues is batch failures, with approximately 7% of batches failing during production....
Pharma & Life Sciences

Navigating Complexities: The Future of Growth in Lifesciences and Biotech Lies in a Genuine Data-Centric Transformation

By Cedric Berger, Head of Knowledge Extraction and Integration, Roche
Introduction "Growth"... a revered tenet for mainstream economists and a feared term for cancer patients. Be it applied to economy, business or sociological, physical, or biological systems, growth is inherently linked to complexity, rendering growing systems increasingly challenging to comprehend...
Pharma & Life Sciences

Pharma’s Prescription for Climate Change

By Sunil Thakur, Partner, Quadria Capital
Climate change is one of the most urgent challenges we face today, and every industry must contribute to addressing it. Historically, many industries have been criticized for their role in exacerbating climate change, and rightly so. However, we are...
Pharma & Life Sciences

Unlocking Broader Access to Treatment with Modifier Gene Therapy

Shankar Musunuri, Chairman, CEO & Co-founder, Ocugen
The evolution of gene therapy has transformed treatment possibilities for genetic disorders. Traditional strategies primarily target specific gene mutations by augmenting a defective gene with a functional copy. While groundbreaking, this approach is limited by its narrow focus, which...

Medhealth Outlook serves as the backdoor to the latest technologies and trends in the healthcare, pharma, and medical industries.

The publication follows an inside/outside approach that allows viewers to witness varied and balanced perspectives.

In presenting what we find through interviews, features, and stunning artwork, we endeavor to be your inspiring source for print and online in-depth journalism covering the tech community powering the medical industries.

Latest News

Current Edition

© 2025. medhealthoutlook.com